Inverness Counsel LLC Merck & Co., Inc. Transaction History

Inverness Counsel LLC

$1.8 Billion
Q3 2022

A detailed history of Inverness Counsel LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Inverness Counsel LLC holds 233,298 shares of MRK stock, worth $22.9 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

233,298

Previous 131,661 77.2%

Holding current value

$22.9 Million

Previous $12 Million 67.38%

% of portfolio

1.12%

Previous 0.67%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	BUY	$84.53 - $94.96 $8.59 Million - $9.65 Million	101,637 Added 77.2%	233,298 $20.1 Million
Q2 2022 Jul 20, 2022	BUY	$83.49 - $94.64 $10.1 Million - $11.4 Million	120,471 Added 1076.6%	131,661 $12 Million
Q1 2022 May 05, 2022	BUY	$73.51 - $82.4 $9,923 - $11,124	135 Added 1.22%	11,190 $918,000
Q4 2021 Feb 07, 2022	SELL	$72.28 - $90.54 $183,446 - $229,790	-2,538 Reduced 18.67%	11,055 $847,000
Q3 2021 Nov 02, 2021	SELL	$71.68 - $78.83 $22,364 - $24,594	-312 Reduced 2.24%	13,593 $1.02 Million
Q2 2021 Aug 10, 2021	SELL	$70.31 - $77.77 $161,853 - $179,026	-2,302 Reduced 14.2%	13,905 $1.08 Million
Q1 2021 May 04, 2021	SELL	$68.86 - $81.11 $284,254 - $334,822	-4,128 Reduced 20.3%	16,207 $1.25 Million
Q4 2020 Jan 27, 2021	SELL	$71.77 - $79.65 $3,086 - $3,424	-43 Reduced 0.21%	20,335 $1.66 Million
Q3 2020 Nov 03, 2020	SELL	$73.18 - $82.95 $26,052 - $29,530	-356 Reduced 1.72%	20,378 $1.69 Million
Q2 2020 Aug 10, 2020	SELL	$70.42 - $80.13 $25,632 - $29,167	-364 Reduced 1.73%	20,734 $1.6 Million
Q1 2020 May 05, 2020	BUY	$63.36 - $87.82 $12,608 - $17,476	199 Added 0.95%	21,098 $1.62 Million
Q4 2019 Feb 05, 2020	SELL	$77.58 - $87.54 $17,610 - $19,871	-227 Reduced 1.07%	20,899 $1.9 Million
Q3 2019 Nov 12, 2019	SELL	$76.08 - $82.93 $372,792 - $406,357	-4,900 Reduced 18.83%	21,126 $1.78 Million
Q2 2019 Aug 07, 2019	SELL	$69.84 - $81.59 $129,762 - $151,594	-1,858 Reduced 6.66%	26,026 $2.18 Million
Q1 2019 May 09, 2019	SELL	$69.58 - $79.36 $80,017 - $91,264	-1,150 Reduced 3.96%	27,884 $2.32 Million
Q4 2018 Jan 29, 2019	SELL	$65.24 - $75.71 $101,578 - $117,880	-1,557 Reduced 5.09%	29,034 $2.12 Million
Q3 2018 Oct 30, 2018	SELL	$57.69 - $67.84 $29,479 - $34,666	-511 Reduced 1.64%	30,591 $2.17 Million
Q2 2018 Aug 02, 2018	SELL	$50.83 - $59.72 $214,299 - $251,779	-4,216 Reduced 11.94%	31,102 $1.89 Million
Q1 2018 May 02, 2018	SELL	$50.96 - $59.23 $1.01 Million - $1.17 Million	-19,803 Reduced 35.93%	35,318 $1.92 Million
Q4 2017 Feb 02, 2018	SELL	$51.62 - $61.64 $21.1 Million - $25.1 Million	-408,000 Reduced 88.1%	55,121 $3.1 Million
Q3 2017 Oct 17, 2017	BUY	$58.67 - $63.13 $27.2 Million - $29.2 Million	463,121	463,121 $29.7 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inverness Counsel LLC , based on Form 13F filings with the SEC.

News

Stay updated on Inverness Counsel LLC with notifications on news.

Account

Inverness Counsel LLC Merck & Co., Inc. Transaction History